Comparative efficacy of omega-3 polyunsaturated fatty acids on major cardiovascular events: A network meta-analysis of randomized controlled trials
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
The role of omega-3 polyunsaturated fatty acids (PUFAs) in primary and secondary prevention on major cardiovascular events (MCE) is inconclusive due to the potential heterogeneity in study designs of formulas, dosages, and ratios of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) from the findings of previous randomized controlled trials (RCTs). Here we conducted a comprehensive narrative review of pre-clinical studies and updated a network meta-analysis (NMA) to determine the comparative efficacy against MCE with different EPA/DHA dosages and formulas. We found that pure EPA was ranked the best option in the secondary prevention (hazard ratio: 0.72, 95% confidence interval: 0.65 to 0.81) from the NMA of 39 RCTs with 88,359 participants. There was no evidence of omega-3 PUFAs' efficacy in primary prevention. The mechanisms of omega-3 PUFAs' cardiovascular protection might link to the effects of anti-inflammation and stabilization of endothelial function from PUFA's derivatives including eicosanoids and the special pre-resolving mediators (SPMs).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Particularly, effects on coronary revascularization are unclear”
From Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis (2024) · cites this paper as [45]
In the citing paper
“However, meta-analyses of omega-3 trials, whilst assessing major cardiovascular events, have paid no or little attention to the effects on coronary revascularizations.”
From Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis (2024) · cites this paper as [45]
Citations
Cites
The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · International Journal of Surgery · doi:10.1016/j.ijsu.2021.105906 · Cited by 11,748
Cipriani, A., Furukawa, T. A., Salanti, G., Chaimani, A., Atkinson, L. Z., Ogawa, Y., Leucht, S., Ruhe, H. G., Turner, E. H., Higgins, J. P. T., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32802-7 · Cited by 3,541
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Ketchum, S. B., Doyle, R. T., Juliano, R. A., Jiao, L., Granowitz, C., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812792 · Cited by 3,317
Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk
Zhu, W., Gregory, J. C., Org, E., Buffa, J. A., Gupta, N., Wang, Z., Li, L., Fu, X., Wu, Y., Mehrabian, M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.011 · Cited by 1,968
Self-citationPuhan, M. A., Schunemann, H. J., Murad, M. H., Li, T., Brignardello-Petersen, R., Singh, J. A., Kessels, A. G., Guyatt, G. H., & for the GRADE Working Group (2014) · BMJ · doi:10.1136/bmj.g5630 · Cited by 1,812
Omega-3 fatty acids and inflammatory processes: from molecules to man
Calder, P. C. (2017) · Biochemical Society Transactions · doi:10.1042/bst20160474 · Cited by 1,456
Marine n−3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer
Manson, J. E., Cook, N. R., Lee, I.-M., Christen, W., Bassuk, S. S., Mora, S., Gibson, H., Albert, C. M., Gordon, D., Copeland, T., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1811403 · Cited by 979
n–3 Fatty Acids and Cardiovascular Events after Myocardial Infarction
Kromhout, D., Giltay, E. J., & Geleijnse, J. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003603 · Cited by 936
n–3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia
The ORIGIN Trial Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203859 · Cited by 929
Bucher, H. C., Hengstler, P., Schindler, C., & Meier, G. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)01114-7 · Cited by 823
Research works printed but not linked: 46
- Matsumoto, 2008, Orally administered eicosapentaenoic acid reduces and stabilizes atherosclerotic lesions in ApoE-deficient mice, Atherosclerosis, 197, 524, 10.1016/j.atherosclerosis.2007.07.023 · DOI
- Radosinska, 2013, Dietary omega-3 fatty acids attenuate myocardial arrhythmogenic factors and propensity of the heart to lethal arrhythmias in a rodent model of human essential hypertension, J. Hypertens., 31, 1876, 10.1097/HJH.0b013e328362215d · DOI
- Imamura, 2018, Omega-3 therapy is associated with reduced gastrointestinal bleeding in patients with continuous-flow left ventricular assist device, Circ Heart Fail, 11, 10.1161/CIRCHEARTFAILURE.118.005082 · DOI
- Zhuang, 2019, Dietary fats in relation to total and cause-specific mortality in a prospective cohort of 521 120 individuals with 16 years of follow-up, Circ. Res., 124, 757, 10.1161/CIRCRESAHA.118.314038 · DOI
- Adkins, 2010, Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids, J. Nutr. Biochem., 21, 781, 10.1016/j.jnutbio.2009.12.004 · DOI · Paper page
- Alexander, 2017, A Meta-analysis of randomized controlled trials and prospective cohort studies of Eicosapentaenoic and docosahexaenoic long-chain Omega-3 fatty acids and coronary heart disease risk, Mayo Clin. Proc., 92, 15, 10.1016/j.mayocp.2016.10.018 · DOI · Paper page
- Aung, 2018, Associations of omega-3 fatty acid supplement use with cardiovascular disease risks: meta-analysis of 10 trials involving 77917 individuals, JAMA Cardiol., 3, 225, 10.1001/jamacardio.2017.5205 · DOI · Paper page
- 2022, Essays Biochem, 64, 397
- Rizos, 2021, Omega-3 supplementation and cardiovascular disease: formulation-based systematic review and meta-analysis with trial sequential analysis, Heart, 107, 150, 10.1136/heartjnl-2020-316780 · DOI · Paper page
- Abdelhamid, 2018, Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease, Cochrane Database Syst. Rev., 11, CD012345
- Kris-Etherton, 2002, Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease, Circulation, 106, 2747, 10.1161/01.CIR.0000038493.65177.94 · DOI · Paper page
- Hsieh, 2019, Effects of different pharmacologic smoking cessation treatments on body weight changes and success rates in patients with nicotine dependence: a network meta-analysis, Obes. Rev., 20, 895, 10.1111/obr.12835 · DOI
- Zeng, 2019, Prevention of postdental procedure bacteremia: a network meta-analysis, J. Dent. Res., 98, 1204, 10.1177/0022034519870466 · doi:10.1177/0022034519870466
- Chen, 2021, Efficacy of pharmacologic treatment in tinnitus patients without specific or treatable origin: a network meta-analysis of randomised controlled trials, EClinicalMedicine, 39, 10.1016/j.eclinm.2021.101080 · DOI
- Wang, 2021, Association of pharmacological prophylaxis with the risk of pediatric emergence delirium after sevoflurane anesthesia: an updated network meta-analysis, J. Clin. Anesth., 75, 10.1016/j.jclinane.2021.110488 · DOI
- Tseng, 2022, The dose- and duration-dependent association between melatonin treatment and overall cognition in Alzheimer’s dementia: a network meta-analysis of randomized placebo-controlled trials, Curr. Neuropharmacol., 20, 1816, 10.2174/1570159X20666220420122322 · DOI
- Tu, 2014, Use of generalized linear mixed models for network meta-analysis, Med. Decis. Mak., 34, 911, 10.1177/0272989X14545789 · DOI · Paper page
- White, 2015, Network meta-analysis, Stata J, 15, 951, 10.1177/1536867X1501500403 · DOI · Paper page
- Salanti, 2011, Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial, J. Clin. Epidemiol., 64, 163, 10.1016/j.jclinepi.2010.03.016 · DOI · Paper page
- Averna, 2021, Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: a statement from a European atherosclerosis society task force, Atherosclerosis, 325, 99, 10.1016/j.atherosclerosis.2021.03.039 · DOI · Paper page
- Manson, 2012, The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease, Contemp Clin Trials, 33, 159, 10.1016/j.cct.2011.09.009 · DOI · Paper page
- Manson, 2020, Vitamin D, marine n-3 fatty acids, and primary prevention of cardiovascular disease current evidence, Circ. Res., 126, 112, 10.1161/CIRCRESAHA.119.314541 · DOI
- Heshmati, 2019, Omega-3 fatty acids supplementation and oxidative stress parameters: a systematic review and meta-analysis of clinical trials, Pharmacol. Res., 149, 10.1016/j.phrs.2019.104462 · DOI · Paper page
- Johansson, 2015, The marine n-3 PUFA DHA evokes cytoprotection against oxidative stress and protein misfolding by inducing autophagy and NFE2L2 in human retinal pigment epithelial cells, Autophagy, 11, 1636, 10.1080/15548627.2015.1061170 · DOI
- Asano, 1999, Eicosapentaenoic acid inhibits vasopressin-activated Ca2+ influx and cell proliferation in rat aortic smooth muscle cell lines, Eur. J. Pharmacol., 379, 199, 10.1016/S0014-2999(99)00476-8 · DOI
- Mason, 2015, Eicosapentaenoic acid inhibits glucose-induced membrane cholesterol crystalline domain formation through a potent antioxidant mechanism, Biochim. Biophys. Acta, 1848, 502, 10.1016/j.bbamem.2014.10.016 · DOI · Paper page
- Allam-Ndoul, 2017, Effect of different concentrations of omega-3 fatty acids on stimulated THP-1 macrophages, Genes Nutr., 12, 7, 10.1186/s12263-017-0554-6 · DOI
- Brown, 2020, Mechanisms underlying N3-PUFA regulation of white adipose tissue endocrine function, Curr. Opin. Pharmacol., 52, 40, 10.1016/j.coph.2020.04.009 · DOI
- Oh, 2010, GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects, Cell, 142, 687, 10.1016/j.cell.2010.07.041 · DOI · Paper page
- Custers, 2022, Dietary lipids from body to brain, Prog. Lipid Res., 85, 10.1016/j.plipres.2021.101144 · DOI
- Michell, 2020, Mike Wakelam: an appreciation, Essays Biochem., 64, 397, 10.1042/EBC20200042 · doi:10.1042/ebc20200042
- Crupi, 2022, Role of EPA in inflammation: mechanisms, effects, and clinical relevance, Biomolecules, 12, 10.3390/biom12020242 · DOI
- Serhan, 2008, Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators, Nat Rev Immunol, 8, 349, 10.1038/nri2294 · DOI · Paper page
- Watanabe, 2020, Prevention of cardiovascular events with omega-3 polyunsaturated fatty acids and the mechanism involved, J. Atheroscler. Thromb., 27, 183, 10.5551/jat.50658 · DOI
- Tang, 2019, The status of omega-3 PUFAs influence chronic unpredicted mild stress-induced metabolic side effects in rats through INSIG/SREBP pathway, Food Funct., 10, 4649, 10.1039/C9FO00076C · DOI
- Gnoni, 2016, Dietary long-chain unsaturated fatty acids acutely and differently reduce the activities of lipogenic enzymes and of citrate carrier in rat liver, J. Physiol. Biochem., 72, 485, 10.1007/s13105-016-0495-3 · DOI
- Shemesh, 2019, Hypertriglyceridemia-related pancreatitis in patients with type 2 diabetes: links and risks, Diabetes Metab Syndr Obes, 12, 2041, 10.2147/DMSO.S188856 · DOI
- Grevengoed, 2021, An abundant biliary metabolite derived from dietary omega-3 polyunsaturated fatty acids regulates triglycerides, J. Clin. Invest., 131, 10.1172/JCI143861 · DOI
- Coker, 2022, Linking anaerobic gut bacteria and cardiovascular disease, Nat. Microbiol., 7, 14, 10.1038/s41564-021-01009-4 · DOI
- Chang, 2014, The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition, Proc. Natl. Acad. Sci. U. S. A., 111, 2247, 10.1073/pnas.1322269111 · DOI · Paper page
- Rousseau, 2021, Microbiota, a new playground for the omega-3 polyunsaturated fatty acids in cardiovascular diseases, Mar Drugs, 19, 10.3390/md19020054 · DOI
- Wawrzyniak, 2021, Nutritional lipids and mucosal inflammation, Mol. Nutr. Food Res., 65
- Zhang, 2019, Potential of omega-3 polyunsaturated fatty acids in managing chemotherapy- or radiotherapy-related intestinal microbial dysbiosis, Adv. Nutr., 10, 133, 10.1093/advances/nmy076 · DOI
- Riviere, 2016, Bifidobacteria and butyrate-producing colon bacteria: importance and strategies for their stimulation in the human gut, Front. Microbiol., 7, 979, 10.3389/fmicb.2016.00979 · DOI · Paper page
- Bryhn, 2006, The bioavailability and pharmacodynamics of different concentrations of omega-3 acid ethyl esters, Prostaglandins Leukot Essent Fatty Acids, 75, 19, 10.1016/j.plefa.2006.04.003 · DOI
- Maki, 2018, Omega-6 polyunsaturated fatty acids and cardiometabolic health: current evidence, controversies, and research gaps, Adv. Nutr., 9, 688, 10.1093/advances/nmy038 · DOI
Cited by
Dinu, M., Sofi, F., Lotti, S., Colombini, B., Mattioli, A. V., Catapano, A. L., Casula, M., Baragetti, A., Wong, N. D., Steg, P. G., et al. (2024) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwae184 · Cited by 43
Metadata
- Authors
- Yang, B., Tseng, P.-T., Hu, X., Zeng, B.-Y., Chang, J. P.-C., Liu, Y., Chu, W.-J., Zhang, S.-S., Zhou, Z.-L., Chu, C.-S., Chang, C.-H., Tu, Y.-K., Wu, Y.-C., Stubbs, B., Carvalho, A. F., Lin, P.-Y., Matsuoka, Y. J., Suen, M.-W., & Su, K.-P.
- Venue
- Progress in Lipid Research
- Publisher
- Elsevier BV
- Published
- 2022-11
- Volume
- 88
- Pages
- 101196
- ISSN
- 0163-7827
- Cited by
- 21
- References
- 35
- Language
- en
- Update notices
- erratum (2023-01-01)
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Funders
- Maudsley Charity
- Chinese Nutrition Society
- Collaboration for Leadership in Applied Health Research and Care - Greater Manchester
- National Health Research Institutes
- Tainan Municipal An-Nan Hospital
- SENSHIN Medical Research Foundation
- China Medical University, Taiwan (CMRC-CMA-2)
- China Medical University Hospital (ICA-CL-2017-03-001)
- National Cancer Center (30-A-17)
- Wenzhou Medical University (89217015)
- Japan Society for the Promotion of Science (17H04253)
- Ministry of Education (DMR-109-102, DMR-HHC-110-10, DMR-HHC-109-11, DMR-103-084, DMR-107-204, DMR-108-216, CMU 110-AWARD-02, DMR-HHC-109-12, DMR-110-124, CMU108-SR-106, CRS-108-048, DMR-106-225, DMR-109-244, DMR-102-076)
- NIHR Collaboration for Leadership in Applied Health Research and Care South London
- Ministry of Health, Labour and Welfare (H30-Cancer Policy-General-005)
- King's College London
- Ministry of Science and Technology, Taiwan (109\u201340, 111\u201348, ANHRF 109\u201331, 110\u201345, 111\u201327, 111\u201347, 110\u201344, 111\u201328, 110\u201326, 111\u201352, 110\u20132314-B-039-029-MY3, 110\u20132320-B-039-047-MY3, 111\u20132321-B-006-008, 110\u20132813-C-039-327-B, 110\u20132321-B-006-004, 109\u20132320-B-038-057-MY3, 110\u20132811-B-039-507, 111\u20132314-B-039-041-MY3, 110\u20132320-B-039-048-MY2, 109\u20132320-B-039-066)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparative efficacy of omega-3 polyunsaturated fatty acids on major cardiovascular events: A network meta-analysis of randomized controlled trials. https://app.cochat.ai/papers/10.1016/j.plipres.2022.101196
- The paper
- Yang, B., Tseng, P.-T., Hu, X., Zeng, B.-Y., Chang, J. P.-C., Liu, Y., Chu, W.-J., Zhang, S.-S., Zhou, Z.-L., Chu, C.-S., Chang, C.-H., Tu, Y.-K., Wu, Y.-C., Stubbs, B., Carvalho, A. F., Lin, P.-Y., Matsuoka, Y. J., Suen, M.-W., & Su, K.-P. (2022). Comparative efficacy of omega-3 polyunsaturated fatty acids on major cardiovascular events: A network meta-analysis of randomized controlled trials. Progress in Lipid Research. https://doi.org/10.1016/j.plipres.2022.101196
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.